我們已在上線! 進一步了解
BBC圖示

Virtus Biotech Clinical Trials ETF

名稱 持股市值 交易金額 股數
變動
持股
變動
Goldman Sachs
1
Goldman Sachs
New York
US$264萬 – – –
Credit Suisse
2
Credit Suisse
Switzerland
US$108萬 +US$91.3萬 +26,992 +191%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
US$60.6萬 +US$77.6萬 +22,944 新增
Jane Street
4
Jane Street
New York
US$47.1萬 -US$133萬 -39,267 -69%
LPL Financial
5
LPL Financial
California
US$38.9萬 -US$36.5萬 -10,783 -44%
Virtu KCG Holdings
6
Virtu KCG Holdings
New York
US$38.4萬 -US$56.5萬 -16,708 -53%
Citadel Advisors
7
Citadel Advisors
Florida
US$33.3萬 +US$42.6萬 +12,603 新增
Ladenburg Thalmann Financial Services
8
Ladenburg Thalmann Financial Services
Florida
US$13.2萬 +US$9.47萬 +2,800 +127%
Morgan Stanley
9
Morgan Stanley
New York
US$3.6萬 +US$4.4萬 +1,300 +1,857%
Creative Planning
10
Creative Planning
Kansas
US$2.5萬 +US$3.26萬 +964 新增
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
US$1.8萬 +US$2.34萬 +691 新增
Tower Research Capital (TRC)
12
Tower Research Capital (TRC)
New York
US$1.7萬 +US$2.19萬 +646 +16,150%
American International Group
13
American International Group
New York
US$7,000 – – –
Next Financial Group
14
Next Financial Group
Texas
US$5,000 +US$6,901 +204 新增
UBS Group
15
UBS Group
Switzerland
US$2,000 -US$2.64萬 -781 -91%
Regal Investment Advisors
16
Regal Investment Advisors
Michigan
US$2,000 +US$3,383 +100 新增
Baker Avenue Asset Management
17
Baker Avenue Asset Management
California
– -US$25.4萬 -7,010 已平倉